Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
David Moatazedi | CEO and President | 2024-03-27 | 6,236 | $13.86 | $86.43kSell |
Rui Avelar | Chief Medical Officer Head of Research and Development | 2024-03-19 | 27,603 | $13.92 | $384.34kSell |
David Moatazedi | President CEO | 2024-03-19 | 96,566 | $13.92 | $1.34MSell |
Sandra Beaver | Chief Financial Officer | 2024-03-19 | 5,672 | $13.92 | $78.98kSell |
Rui Avelar | Chief Medical Officer Head of Research and Development | 2024-02-22 | 1,821 | $13.08 | $23.82kSell |
Sandra Beaver | Chief Financial Officer | 2024-02-22 | 1,821 | $13.08 | $23.82kSell |
David Moatazedi | President CEO | 2024-02-22 | 7,706 | $13.08 | $100.80kSell |
Karah Herdman Parschauer | Director | 2024-01-30 | 11,931 | $13.14 | $156.74kSell |
David Moatazedi | President and Chief Executive Officer | 2023-12-08 | 31,300 | $9.73 | $304.52kSell |
David Moatazedi | President and Chief Executive Officer | 2023-12-06 | 51,348 | $10.09 | $517.90kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Medytox Inc | 18.36% | 10,640,826 | $123.86M | Insider |
Stonepine Capital Management LLC | 9.20% | 5,333,004 | $62.08M | Institution |
Alphaeon 1 LLC | 7.27% | 4,214,871 | $49.06M | Insider |
Perceptive Advisors LLC | 6.84% | 3,963,424 | $46.13M | Institution |
Blackrock Inc | 5.76% | 3,339,377 | $38.87M | Institution |
Tang Capital Management LLC | 5.35% | 3,097,399 | $36.05M | Institution |
Vanguard Group Inc | 5.08% | 2,943,512 | $34.26M | Institution |
Nantahala Capital Management LLC | 5.02% | 2,910,849 | $33.88M | Institution |
Morgan Stanley | 4.46% | 2,582,711 | $30.06M | Institution |
Great Point Partners LLC | 3.45% | 2,000,000 | $23.28M | Institution |